162 related articles for article (PubMed ID: 36139516)
1. Early Dynamics of Quantitative
Krausewitz P; Kluemper N; Richter AP; Büttner T; Kristiansen G; Ritter M; Ellinger J
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139516
[TBL] [Abstract][Full Text] [Related]
2. Potential of quantitative SEPT9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort study.
Bergheim J; Semaan A; Gevensleben H; Groening S; Knoblich A; Dietrich J; Weber J; Kalff JC; Bootz F; Kristiansen G; Dietrich D
Br J Cancer; 2018 May; 118(9):1217-1228. PubMed ID: 29610456
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of Monitoring Response to Metastatic Prostate Cancer Treatment with a Methylation-Based Circulating Tumor DNA Approach.
Büttner T; Dietrich D; Zarbl R; Klümper N; Ellinger J; Krausewitz P; Ritter M
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339235
[TBL] [Abstract][Full Text] [Related]
4. Treatment Response Monitoring in Patients with Advanced Malignancies Using Cell-Free SHOX2 and SEPT9 DNA Methylation in Blood: An Observational Prospective Study.
de Vos L; Jung M; Koerber RM; Bawden EG; Holderried TAW; Dietrich J; Bootz F; Brossart P; Kristiansen G; Dietrich D
J Mol Diagn; 2020 Jul; 22(7):920-933. PubMed ID: 32361006
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of DNA methylation levels of
Grossi I; Assoni C; Lorini L; Smussi D; Gurizzan C; Grisanti S; Paderno A; Mattavelli D; Piazza C; Pelisenco IA; De Petro G; Salvi A; Bossi P
Oncol Rep; 2024 Mar; 51(3):. PubMed ID: 38299234
[TBL] [Abstract][Full Text] [Related]
6. Comparison of quantification algorithms for circulating cell-free DNA methylation biomarkers in blood plasma from cancer patients.
de Vos L; Gevensleben H; Schröck A; Franzen A; Kristiansen G; Bootz F; Dietrich D
Clin Epigenetics; 2017; 9():125. PubMed ID: 29213339
[TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation of
Branchi V; Schaefer P; Semaan A; Kania A; Lingohr P; Kalff JC; Schäfer N; Kristiansen G; Dietrich D; Matthaei H
Clin Epigenetics; 2016; 8():133. PubMed ID: 27999621
[TBL] [Abstract][Full Text] [Related]
8. Circulating Cell-Free SEPT9 DNA Methylation in Blood Is a Biomarker for Minimal Residual Disease Detection in Head and Neck Squamous Cell Carcinoma Patients.
Dietrich D; Weider S; de Vos L; Vogt TJ; Färber M; Zarbl R; Hunecke A; Glosch AK; Gabrielpillai J; Bootz F; Bauernfeind FG; Kramer FJ; Kristiansen G; Brossart P; Strieth S; Franzen A
Clin Chem; 2023 Sep; 69(9):1050-1061. PubMed ID: 37477541
[TBL] [Abstract][Full Text] [Related]
9. Cell-Free
Jung M; Ellinger J; Gevensleben H; Syring I; Lüders C; de Vos L; Pützer S; Bootz F; Landsberg J; Kristiansen G; Dietrich D
Clin Chem; 2019 Apr; 65(4):559-568. PubMed ID: 30626634
[TBL] [Abstract][Full Text] [Related]
10. Free-Circulating Methylated DNA in Blood for Diagnosis, Staging, Prognosis, and Monitoring of Head and Neck Squamous Cell Carcinoma Patients: An Observational Prospective Cohort Study.
Schröck A; Leisse A; de Vos L; Gevensleben H; Dröge F; Franzen A; Wachendörfer M; Schröck F; Ellinger J; Teschke M; Wilhelm-Buchstab T; Landsberg J; Holdenrieder S; Hartmann G; Field JK; Bootz F; Kristiansen G; Dietrich D
Clin Chem; 2017 Jul; 63(7):1288-1296. PubMed ID: 28515105
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant and malignant pleural effusions.
Dietrich D; Jung M; Puetzer S; Leisse A; Holmes EE; Meller S; Uhl B; Schatz P; Ivascu C; Kristiansen G
PLoS One; 2013; 8(12):e84225. PubMed ID: 24386354
[TBL] [Abstract][Full Text] [Related]
12.
Semaan A; van Ellen A; Meller S; Bergheim D; Branchi V; Lingohr P; Goltz D; Kalff JC; Kristiansen G; Matthaei H; Pantelis D; Dietrich D
Clin Epigenetics; 2016; 8():100. PubMed ID: 27660666
[TBL] [Abstract][Full Text] [Related]
13. Cell-Free DNA Methylation of Selected Genes Allows for Early Detection of the Major Cancers in Women.
Nunes SP; Moreira-Barbosa C; Salta S; Palma de Sousa S; Pousa I; Oliveira J; Soares M; Rego L; Dias T; Rodrigues J; Antunes L; Henrique R; Jerónimo C
Cancers (Basel); 2018 Sep; 10(10):. PubMed ID: 30261643
[TBL] [Abstract][Full Text] [Related]
14. Circulating Cell-Free SHOX2 DNA Methylation Is a Predictive, Prognostic, and Monitoring Biomarker in Adjuvant and Palliative Anti-PD-1-Treated Melanoma.
Fietz S; Diekmann E; de Vos L; Zarbl R; Hunecke A; Glosch AK; Färber M; Sirokay J; Hoffmann F; Fröhlich A; Franzen A; Strieth S; Landsberg J; Dietrich D
Clin Chem; 2024 Mar; 70(3):516-527. PubMed ID: 38300881
[TBL] [Abstract][Full Text] [Related]
15. Methylation of FBN1, SPG20, ITF2, RUNX3, SNCA, MLH1, and SEPT9 genes in circulating cell-free DNA as biomarkers of colorectal cancer.
Alizadeh-Sedigh M; Fazeli MS; Mahmoodzadeh H; Sharif SB; Teimoori-Toolabi L
Cancer Biomark; 2022; 34(2):221-250. PubMed ID: 34957998
[TBL] [Abstract][Full Text] [Related]
16. Detection of SHOX2 DNA methylation by methylation-specific PCR in non-small cell lung cancer.
Feng H; Shao W; Du L; Qing X; Zhang Z; Liang C; Liu D
Transl Cancer Res; 2020 Oct; 9(10):6070-6077. PubMed ID: 35117218
[TBL] [Abstract][Full Text] [Related]
17. Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease.
Weiss G; Schlegel A; Kottwitz D; König T; Tetzner R
J Thorac Oncol; 2017 Jan; 12(1):77-84. PubMed ID: 27544059
[TBL] [Abstract][Full Text] [Related]
18. Detection of methylated septin 9 in tissue and plasma of colorectal patients with neoplasia and the relationship to the amount of circulating cell-free DNA.
Tóth K; Wasserkort R; Sipos F; Kalmár A; Wichmann B; Leiszter K; Valcz G; Juhász M; Miheller P; Patai ÁV; Tulassay Z; Molnár B
PLoS One; 2014; 9(12):e115415. PubMed ID: 25526039
[TBL] [Abstract][Full Text] [Related]
19.
Holmes EE; Goltz D; Sailer V; Jung M; Meller S; Uhl B; Dietrich J; Röhler M; Ellinger J; Kristiansen G; Dietrich D
Clin Epigenetics; 2016; 8():104. PubMed ID: 27708722
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant, and malignant ascites.
Jung M; Pützer S; Gevensleben H; Meller S; Kristiansen G; Dietrich D
Clin Epigenetics; 2016; 8():24. PubMed ID: 26937257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]